Gibson Dunn Advised Immedica Pharma on Acquisition of Neurocrine Group

Gibson Dunn Advised Immedica Pharma on Acquisition of Neurocrine Group

Gibson Dunn advised Immedica Pharma AB on the acquisition of Neurocrine Group Limited.

Headquartered in Stockholm, Sweden, Immedica focuses on the commercialization of medicines for rare diseases and specialty care products.

The Gibson Dunn London team was led by Wim De Vlieger (Partner) and Jakob Egle (Partner) and includes Branden Berns (Partner) and Lucy Carr (Associate), Alex Eldredge (Associate), and Tracey Tomlinson (Associate).

The other side of team included Alison Beal (Partner) and Chris Puttock (Associate) and Ioana Burtea (Associate) advised on Privacy/IP/IT matters; Karen Spindler (Partner) and Carson Zheng (Associate) advised on Licensing matters; James Cox (Partner) and Georgia Derbyshire (Associate) advised on Employment matters; Melissa Farrar (Partner), Irene Polieri (Associate) and Victor Tong advised (Associate) on Anti-Bribery/Anti-Corruption/Sanctions matters; Christian Riis-Madsen (Partner) and Jonas Jousma (Associate) and Alex Delipallas-O’Donnell (Associate) advised on Antitrust/Foreign Direct Investment matters; Sandy Bhogal (Partner), James Jennings (Partner) and Bridget English (Of Counsel) advised on Tax matters.

Click to know more about Gibson Dunn

If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.